Figure S1. Expression of Nrf1/TCF11 and NQO1 in three pairs of shNrf1-and shNC-expressing cell lines that were treated with 10 mol/L of MG132 or vehicle control (DMSO) for 4 h. The intensity of those immunoblots (as shown in Figure 1C ) was quantified by the Quantity One 4.5.2 software and are shown graphically. The data are shown as mean  SD (n = 3), with significant decreases of shNrf1 (* p < 0.05; ** p < 0.01), when compared to the shNC values.
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Figure S2
Figure S2. Distinct expression levels of multiple Nrf1 isoforms. (A) The HepG2 cells, that had been allowed for stably expression of shNrf1 or shNC packaged in a lentivirus-transduced system, were treated with 10 mol/L of MG132 (+) or a vehicle DMSO (−) for 24 h before being subjected to evaluation of distinct Nrf1 isoforms by Western blotting with a specific antibody against Nrf1 (made in our own laboratory). (B, C) Both the histogram (B) and table (C) of the sequencing reads that distribute to a reference in the concrete and complete genome-wide level of human Nrf1 gene with distinct transcripts that were compared between two samples of shNrf1-and shNC-expressing HepG2 cell lines. Knockdown of Nrf1 by shNrf1 caused significant decreases (* p < 0.05; ** p < 0.01) or significant increases ($, p < 0.05) relative to the counterpart values measured from shNC cells. . Then statistic analysis reveals that significant increases ($, p < 0.05) and significant decreases (* p < 0.05; ** p < 0.01) were determined by comparison of these two grouped data measured from the core cancer and para-carcinoma tissues as indicated. Subsequently, the protein abundances of -catenin (A) and Nrf1 (B) were determined by Western blotting with their respective antibodies. The intensity of their immunoblots were quantified by the ImageJ software, and the data are shown graphically (C). The [X]t/[X]CHX-0h represents a relative amount of indicated proteins at the indicated times 't' that had been normalized to the cells only treated with CHX for 0 h. Notably, the stability of -catenin and Nrf1 (with distinct isoforms) was estimated by their half-lives (t1/2) after treatment of cells with CHX alone or plus MG132.
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